SBTX - Silverback Therapeut...

Valuation of Silverback Therapeutics, Inc.(SBTX), Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics fo

Silverback Therapeutics, Inc.

SBTX

NASDAQ

Inactive Equity

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

5.87 USD

0.06 (1.02%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Valuation Date:

Nov 9, 2022 12:00 AM

Share Price on Valuation Date

$5.87

Stock Beta

Shares Outstanding

93770200

FMP

Home Terms of Service Privacy Policy Blog FAQs Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.